Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study of the LEAD Clinical Trial
Authors:
- Robyn H GuymerRGRobyn H Guymer
- Fred K ChenFCFred K Chen
- Nicole TindillNTNicole Tindill
- Zhichao WuZWZhichao Wu
- LEAD Study GroupLGLEAD Study Group
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Ophthalmology Retina
- Vol. 5 (12) , 1196-1203
Abstract
No abstract availableKeywords
Funding Information
- Bayer
- National Health and Medical Research Council (GNT1054712, APP1104985, MRF1142962, GNT1103013, APP1027624, GNT1128343)
- State Government of Victoria
- Novartis
This publication has 20 references indexed in Scilit:
- Nanosecond laser therapy reverses pathologic and molecular changes in age‐related macular degeneration without retinal damageThe FASEB Journal, 2014
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysisThe Lancet Global Health, 2014
- Nanosecond‐laser application in intermediate AMD: 12‐month results of fundus appearance and macular functionClinical & Experimental Ophthalmology, 2013
- Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular DegenerationJAMA, 2013
- Clinical Classification of Age-related Macular DegenerationOphthalmology, 2013
- Laser-Mediated Activation of Human Retinal Pigment Epithelial Cells and Concomitant Release of Matrix MetalloproteinasesInvestigative Ophthalmology & Visual Science, 2012
- Nanosecond pulse lasers for retinal applicationsLasers in Surgery and Medicine, 2011
- Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible PatientsOphthalmology, 2006
- Prophylactic Laser Treatment Hastens Choroidal Neovascularization in Unilateral Age-Related Maculopathy: Final Results of the Drusen Laser StudyAmerican Journal of Ophthalmology, 2006
- Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial11The members of the Choroidal Neovascularization Prevention Trial Research Group are listed in the appendix.Ophthalmology, 2003